Underactive Bladder Syndrome Epidemiology Forecast 2026-2035

Underactive bladder syndrome (UAB) is a lower urinary tract dysfunction characterized by impaired detrusor muscle activity leading to incomplete bladder emptying and significant morbidity. According to the underactive bladder syndrome epidemiology forecast, prevalence is increasing globally, particularly among older adults. As per Ganesh Uttam Asole et al., 2025, the prevalence is reported to be around 10‑15 % among patients with lower urinary tract dysfunction. Globally, epidemiological data remain limited, with higher rates observed among older adults and males.

Underactive Bladder Syndrome Epidemiology Forecast Report Coverage

The analyst's “Underactive Bladder Syndrome Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of underactive bladder syndrome. It projects the future incidence and prevalence rates of underactive bladder syndrome cases across various populations. The study covers age, gender, and type as major determinants of the underactive bladder syndrome population. The report highlights patterns in the prevalence of underactive bladder syndrome over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of underactive bladder syndrome in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Underactive Bladder Syndrome Understanding: Disease Overview

Underactive bladder syndrome (UAB) is a chronic urological condition characterized by the bladder’s inability to contract effectively, resulting in incomplete emptying of urine. This condition often arises due to detrusor muscle dysfunction, nerve damage, or obstruction in the urinary tract obstruction. UAB can be idiopathic or secondary to neurological disorders, diabetes mellitus, or age-related changes in bladder function. Patients typically experience symptoms such as urinary retention, a weak urinary stream, and increased urinary frequency. Clinically, UAB may be classified into primary types, including idiopathic underactive bladder and neurogenic underactive bladder, depending on the underlying cause and pathophysiology.

Underactive Bladder Syndrome Epidemiology Perspective

The underactive bladder syndrome epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for underactive bladder syndrome epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for underactive bladder syndrome and associated trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Cheng-Yen Tsai et al., 2023, the prevalence of underactive bladder (UAB) syndrome is rising due to an aging population, with detrusor underactivity (DU) affecting 25-48% of elderly men and 12-24% of elderly women with lower urinary tract symptoms.
• As per Coloplast Corp., 48% of elderly men and 45% of elderly women face difficulty emptying the bladder due to DU or UAB. The incidence in patients under 50 years ranges between 9% and 28%, highlighting age-related variations.
• According to Noritoshi Sekido et al., 2024, an online Japanese survey of 6210 participants reported UAB in 9.29% of men and 3.98% of women, with affected individuals showing higher vulnerability to reduced mobility, falls, and multiple comorbidities.
• As per Charlotte Phelps et al., 2023, over 45% of elderly men and women with lower urinary tract symptoms exhibit UAB, often leading to urinary retention, incomplete bladder emptying, nocturia, urgency, and hesitancy.
• Epidemiological studies indicate UAB is more prevalent in older adults, with women showing higher rates of urinary retention secondary to DU, especially when coexisting with bladder outlet obstruction, emphasizing gender-specific differences in incidence.

Country-wise Underactive Bladder Syndrome Epidemiology

The underactive bladder syndrome epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of underactive bladder (UAB) and related lower urinary tract symptoms (LUTS) highlights significant regional variation. According to Elliot Lister et al., 2024, LUTS affect over 60% of adults by the age of 40, with overactive bladder, a common LUT symptom, reported in 10.7% of the global population and 12% of adults in the United Kingdom. In Japan, Noritoshi Sekido et al., 2025, report UAB prevalence at 9.3% in men and 4.0% in women aged 20 years or older, decreasing slightly to 7.0% and 3.7% when excluding benign prostatic hyperplasia or pelvic organ prolapse. Prevalence rises significantly with age, with storage symptoms and comorbidities strongly associated with the condition.

Underactive Bladder Syndrome: Treatment Overview

The management of underactive bladder syndrome focuses on improving bladder emptying and alleviating associated symptoms. Conservative approaches include timed voiding, bladder training, and pelvic floor muscle exercises. Pharmacological therapies, such as parasympathomimetic agents, are used to stimulate detrusor contraction in select cases. In more severe or refractory cases, intermittent self-catheterization or indwelling catheterization may be necessary to prevent urinary retention and infection. Emerging interventions, including neuromodulation therapies, aim to enhance neural signaling to the bladder. Treatment plans are typically individualized, considering patient age, comorbidities, and the underlying etiology of bladder underactivity.

Key Questions Answered

• What are the key findings of underactive bladder syndrome epidemiology in the 8 major markets?
• What will be the total number of patients with underactive bladder syndrome across the 8 major markets during the forecast period?
• What was the country-wise underactive bladder syndrome epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of underactive bladder syndrome patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of underactive bladder syndrome during the forecast period of 2026-2035?
• What are the currently available treatments for underactive bladder syndrome?
• What are the disease risks, signs, symptoms, and unmet needs of underactive bladder syndrome?

Scope of the Underactive Bladder Syndrome Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of underactive bladder syndrome based on several factors.
• Underactive Bladder Syndrome Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The underactive bladder syndrome report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.